DEUTSCHE BANK AG\
BankPosition in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in MRVI
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$2,428,861
-$325,614 QoQ
Shares Held
858,255
+1.3% QoQ
Ownership
0.332%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,973,467,737 across 247 Biotechnology names. MRVI ranks #93 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in MRVI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,428,861 | 858,255 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $2,754,475 | 847,531 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $5,418,692 | 1,888,046 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,517,166 | 1,874,343 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,579,647 | 2,072,239 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $6,739,681 | 1,236,639 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $15,507,581 | 1,866,135 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $11,648,009 | 1,626,817 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $12,263,992 | 1,414,532 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $9,265,184 | 1,414,532 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $245,090 | 24,509 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $18,138,662 | 1,459,265 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,955,722 | 282,350 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,085,012 | 75,822 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $154,813 | 6,064 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $165,828 | 5,837 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $162,594 | 4,610 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $999,901 | 23,864 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $37,436,111 | 762,757 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $3,077,250 | 73,742 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $3,416,377 | 95,858 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,513,269 | 53,949 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||